129 related articles for article (PubMed ID: 17583556)
1. Mirk/Dyrk1B in cancer.
Friedman E
J Cell Biochem; 2007 Oct; 102(2):274-9. PubMed ID: 17583556
[TBL] [Abstract][Full Text] [Related]
2. The survival kinase Mirk/dyrk1B is activated through Rac1-MKK3 signaling.
Jin K; Lim S; Mercer SE; Friedman E
J Biol Chem; 2005 Dec; 280(51):42097-105. PubMed ID: 16257974
[TBL] [Abstract][Full Text] [Related]
3. Mirk/dyrk1B is a Rho-induced kinase active in skeletal muscle differentiation.
Deng X; Ewton DZ; Pawlikowski B; Maimone M; Friedman E
J Biol Chem; 2003 Oct; 278(42):41347-54. PubMed ID: 12902328
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
Hu J; Deng H; Friedman EA
Int J Cancer; 2013 May; 132(10):2258-69. PubMed ID: 23114871
[TBL] [Abstract][Full Text] [Related]
5. Mirk protein kinase is activated by MKK3 and functions as a transcriptional activator of HNF1alpha.
Lim S; Jin K; Friedman E
J Biol Chem; 2002 Jul; 277(28):25040-6. PubMed ID: 11980910
[TBL] [Abstract][Full Text] [Related]
6. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
Jin K; Park S; Ewton DZ; Friedman E
Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
[TBL] [Abstract][Full Text] [Related]
7. Mirk regulates the exit of colon cancer cells from quiescence.
Jin K; Ewton DZ; Park S; Hu J; Friedman E
J Biol Chem; 2009 Aug; 284(34):22916-25. PubMed ID: 19542220
[TBL] [Abstract][Full Text] [Related]
8. Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts.
Mercer SE; Ewton DZ; Deng X; Lim S; Mazur TR; Friedman E
J Biol Chem; 2005 Jul; 280(27):25788-801. PubMed ID: 15851482
[TBL] [Abstract][Full Text] [Related]
9. Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2.
Hu J; Nakhla H; Friedman E
Int J Cancer; 2011 Jul; 129(2):307-18. PubMed ID: 20857490
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
Ewton DZ; Hu J; Vilenchik M; Deng X; Luk KC; Polonskaia A; Hoffman AF; Zipf K; Boylan JF; Friedman EA
Mol Cancer Ther; 2011 Nov; 10(11):2104-14. PubMed ID: 21878655
[TBL] [Abstract][Full Text] [Related]
11. Mirk/Dyrk1b mediates cell survival in rhabdomyosarcomas.
Mercer SE; Ewton DZ; Shah S; Naqvi A; Friedman E
Cancer Res; 2006 May; 66(10):5143-50. PubMed ID: 16707437
[TBL] [Abstract][Full Text] [Related]
12. The transcriptional activator Mirk/Dyrk1B is sequestered by p38alpha/beta MAP kinase.
Lim S; Zou Y; Friedman E
J Biol Chem; 2002 Dec; 277(51):49438-45. PubMed ID: 12384504
[TBL] [Abstract][Full Text] [Related]
13. Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.
Gao J; Zheng Z; Rawal B; Schell MJ; Bepler G; Haura EB
Cancer Biol Ther; 2009 Sep; 8(17):1671-9. PubMed ID: 19633423
[TBL] [Abstract][Full Text] [Related]
14. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
15. Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M.
Zou Y; Lim S; Lee K; Deng X; Friedman E
J Biol Chem; 2003 Dec; 278(49):49573-81. PubMed ID: 14500717
[TBL] [Abstract][Full Text] [Related]
16. Mirk/Dyrk1B: a multifunctional dual-specificity kinase involved in growth arrest, differentiation, and cell survival.
Mercer SE; Friedman E
Cell Biochem Biophys; 2006; 45(3):303-15. PubMed ID: 16845176
[TBL] [Abstract][Full Text] [Related]
17. The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer.
Gao J; Yang X; Yin P; Hu W; Liao H; Miao Z; Pan C; Li N
Int J Oncol; 2012 Apr; 40(4):1203-9. PubMed ID: 22159921
[TBL] [Abstract][Full Text] [Related]
18. Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288.
Zou Y; Ewton DZ; Deng X; Mercer SE; Friedman E
J Biol Chem; 2004 Jun; 279(26):27790-8. PubMed ID: 15075324
[TBL] [Abstract][Full Text] [Related]
19. Mirk/dyrk1B Kinase in Ovarian Cancer.
Friedman E
Int J Mol Sci; 2013 Mar; 14(3):5560-75. PubMed ID: 23528858
[TBL] [Abstract][Full Text] [Related]
20. Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by reducing levels of reactive oxygen species.
Deng X; Ewton DZ; Friedman E
Cancer Res; 2009 Apr; 69(8):3317-24. PubMed ID: 19351855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
